Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Chief Tech/Sci/R&D Officer - 2009-07-16
Director of Finance/CFO 60 2022-06-30
Director TitleAgeSince
Director/Board Member 58 2020-07-08
Chairman 68 2021-12-08
Director/Board Member 78 2004-08-31
Date Insider Type Main position Quantity % Market Cap. Importance
7/9/20 Tender

Chief Executive Officer

29,206 0.1196%
7/9/20 Tender

Chief Financial Officer

500 0.0020% -
7/9/20 Tender

Director

102,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 1.41M
+0.88%+0.22%-25.54%+2.37% 170B
-1.46%-0.42%-12.61%+14.38% 111B
-0.26%+0.72%-24.88%+3.96% 107B
-0.03%+0.72%-46.94%-10.20% 75.95B
+0.46%+6.03%+3.12%+70.98% 60.37B
-0.65%+6.59%+11.44%+66.40% 53.53B
+0.31%+0.89%-6.20%-32.06% 49.11B
-1.14%-2.65%-18.96%+14.95% 40.6B
+1.43%-2.10%+27.94%+1.67% 31.47B
Average -0.04%+0.25%-10.29%+14.72% 77.67B
Weighted average by Cap. -0.05%-0.04%-16.25%+12.27%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-